Cyclacel Pharmaceuticals Inc Share Price (NASDAQ: CYCC)

Cyclacel Pharmaceuticals Inc Stock Performance

as on September 12, 2025 at 1:28 am IST

Day's Low
Day's High
$6.1
Day's Price Range
$6.98
$6.26
2.56%
Downside
11.50%
Upside
52 Week's Low
52 Week's High
$3.08
52-Week Price Range
$597.6
$6.26
50.80%
Downside
9446.33%
Upside

Cyclacel Pharmaceuticals Inc share price movements today

Previous Close: $6.77
Open: $6.42
Volume: 332.6K
Day's Low - High: $6.1 - $6.98
52 Week Low - High: $3.08 - $597.6

Cyclacel Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Cyclacel Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Cyclacel Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Cyclacel Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cyclacel Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cyclacel Pharmaceuticals Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.4B	213.96%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.6B	47.7%	28.98	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.8B	-7.13%	14.23	31.37%

Analyst Recommendation on Cyclacel Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Cyclacel Pharmaceuticals Inc. Average target price of $1

Cyclacel Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Cyclacel Pharmaceuticals Inc.

What analysts predicted

-526%DOWNSIDE

Target Price

Current Price

$6.26

Analyzed by

9 Analysts

Target

$1.00

Cyclacel Pharmaceuticals Inc target price $1, a slight downside of -526% compared to current price of $6.26. According to 9 analysts rating.

Cyclacel Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	0	0	0	0	0	0	-	0	-
Gross Profit	0	0	0	0	0	0	0	-	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-5	-5	-6	-5	-2	-3	-1	-3	0	-1
Net Profit Margin	0.00%	-1460.59%	-37700.00%	-17003.23%	-10158.62%	-81425.00%	-19570.00%	0.00%	231.43%	0.00%

Cyclacel Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	0	-	0	-	0	-	0	0	0
Gross Profit	-10	-8	0	-4	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-14	-11	-7	-7	-7	-8	-18	-21	-22	-11
Net Profit Margin	-737.76%	-1398.70%	0.00%	-4858.67%	0.00%	-143695.76%	0.00%	-5683.11%	-5370.24%	-26074.42%

Global Institutional Holdings in Cyclacel Pharmaceuticals Inc

Funds	Holdings
SBI Securities Co Ltd	0%
Archer Investment Corporation	0%
Point72 Asset Management, L.P.	0%
Financial Gravity Wealth, Inc.	0%
HARBOUR INVESTMENTS, INC.	0%

See all

Insights on Cyclacel Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 126.8% return, outperforming this stock by 226.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.6% return, outperforming this stock by 174.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CYCC stock has moved down by -10.4%

About Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, epigenetics and mitosis biology. Its epigenetic/anti-mitotic program is evaluating plogo, a Polo-like kinase 1 (PLK1) inhibitor, in solid tumors and hematological malignancies. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle, and is a regulator of the DNA damage checkpoint. The Company’s plogo is a novel, small-molecule, selective and potent PLK1 inhibitor, which has demonstrated potent and selective target inhibition (PLK1 IC50 approximately 3 nM) and efficacy in human tumor xenografts at non-toxic doses. Its translational biology program supports the development of plogo in solid tumor and hematological malignancy indications. PLK1 over-expressing tumors include colorectal, esophageal, gastric, leukemia, lung, lymphoma, ovarian and squamous cell cancers.

Organisation	Cyclacel Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Cyclacel Pharmaceuticals Inc share price today?

Cyclacel Pharmaceuticals Inc share price today is $6.26 as on September 12, 2025 at 1:28 am IST at the close of the market. Cyclacel Pharmaceuticals Inc share today touched a day high of $6.98 and a low of $6.1.

What is the 52 week high and 52 week low for Cyclacel Pharmaceuticals Inc share?

Cyclacel Pharmaceuticals Inc share touched a 52 week high of $597.6 on October 22, 2024 and a 52 week low of $3.08 on July 7, 2025. Cyclacel Pharmaceuticals Inc stock price today i.e. September 12, 2025 at 1:28 am IST is closed at $6.26,which is 98.95% down from its 52 week high and 103.24% up from its 52 week low.

How to invest in Cyclacel Pharmaceuticals Inc Stock (CYCC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cyclacel Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cyclacel Pharmaceuticals Inc Shares that will get you 0.2396 shares as per Cyclacel Pharmaceuticals Inc share price of $6.26 per share as on September 12, 2025 at 1:28 am IST.

What is the minimum amount required to buy Cyclacel Pharmaceuticals Inc Stock (CYCC) from India?

Indian investors can start investing in Cyclacel Pharmaceuticals Inc (CYCC) shares with as little as ₹88.635 or $1 (as of October 14, 2025 at 6:29 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Cyclacel Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on October 14, 2025 at 6:29 am IST). Based on Cyclacel Pharmaceuticals Inc share’s latest price of $6.26 as on September 12, 2025 at 1:28 am IST, you will get 1.5974 shares of Cyclacel Pharmaceuticals Inc. Learn more about fractional shares .